Crizotinib is a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). Crizotinib is a potential antitumor agent.Form:White SolidMelting Point:202-204°CSolubility:DMSO, MethanolPfizer Compound